Abstract
Groesser et al. demonstrate that pyogenic granuloma is a RAS pathway-driven tumor. This important observation adds yet another manifestation to the growing spectrum of cutaneous "RASopathies" and raises intriguing questions about the relationship between RAS pathway activation and malignancy.
| Original language | English |
|---|---|
| Pages (from-to) | 359-360 |
| Number of pages | 2 |
| Journal | Journal of Investigative Dermatology |
| Volume | 136 |
| Issue number | 2 |
| Early online date | 20 Jan 2016 |
| DOIs |
|
| Publication status | Published - Feb 2016 |